Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.
A new U.S. Food and Drug Administration final rule governing clinical trials held in foreign countries will spark painstaking legal review of pharmaceutical companies' protocols for trials. Although the FDA lacks authority to police clinical trials in other countries, it can and does regulate the types of clinical trial data it requires and accepts from companies applying for new drug approval or marketing approval for a drug or biological product.
The upshot is that pharmaceutical companies will need lawyers' help to design foreign trials to meet U.S. standards if they ever hope to sell drugs tested in those trials in the United States. The new rule, which takes effect on Oct. 27, standardizes the requirements across countries and adds requirements for trials in many countries, lawyers say.
The impact of the FDA's change is also likely to deepen during the next few years as drug companies increasingly embrace overseas clinical trials. An estimated 65% of the top pharmaceutical companies' FDA-regulated clinical trials will be staged outside the United States within three years, compared with 43% today, according to the Tufts Center for the Study of Drug Development Outlook 2008 report.
ENJOY UNLIMITED ACCESS TO THE SINGLE SOURCE OF OBJECTIVE LEGAL ANALYSIS, PRACTICAL INSIGHTS, AND NEWS IN ENTERTAINMENT LAW.
Already a have an account? Sign In Now Log In Now
For enterprise-wide or corporate acess, please contact Customer Service at [email protected] or 877-256-2473
Defining commercial real estate asset class is essentially a property explaining how it identifies — not necessarily what its original intention was or what others think it ought to be. This article discusses, from a general issue-spot and contextual analysis perspective, how lawyers ought to think about specialized leasing formats and the regulatory backdrops that may inform what the documentation needs to contain for compliance purposes.
As courts and discovery experts debate whether hyperlinked content should be treated the same as traditional attachments, legal practitioners are grappling with the technical and legal complexities of collecting, analyzing and reviewing these documents in real-world cases.
How to Convey Your Merits In a Way That Earns Trust, Clients and Distinctions Just as no two individuals have the exact same face, no two lawyers practice in their respective fields or serve clients in the exact same way. Think of this as a "Unique Value Proposition." Internal consideration about what you uniquely bring to your clients, colleagues, firm and industry can provide untold benefits for your law practice.
The ever-evolving digital marketing landscape, coupled with the industry-wide adoption of programmatic advertising, poses a significant threat to the effectiveness and integrity of digital advertising campaigns. This article explores various risks to digital advertising from pixel stuffing and ad stacking to domain spoofing and bots. It will also explore what should be done to ensure ad fraud protection and improve effectiveness.
This article offers practical insights and best practices to navigate the path from roadmap to rainmaking, ensuring your business development efforts are not just sporadic bursts of activity, but an integrated part of your daily success.